Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
Chemical and physical data | |
Formula | C18H17N3O2 |
Molar mass | 307.35 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
Anitrazifen is a drug displaying COX-2 inhibitor activity.
Selective COX-2 inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, COX-2, an enzyme responsible for inflammation and pain. Targeting selectivity for COX-2 reduces the risk of peptic ulceration, and is the main feature of celecoxib, rofecoxib and other members of this drug class.
Pyrazolones / Pyrazolidines | |
---|---|
Salicylates | |
Acetic acid derivatives and related substances | |
Oxicams | |
Propionic acid derivatives (profens) |
|
N-Arylanthranilic acids (fenamates) | |
Coxibs | |
Other | |
Items listed in bold indicate initially developed compounds of specific groups. # WHO-EM † Withdrawn drugs. ‡ Veterinary use medications. |
Receptor (ligands) |
| ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enzyme (inhibitors) |
| ||||||||||||||||||||||||||
Others | |||||||||||||||||||||||||||
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |